Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

The majority of severe visual loss in the United States results from complications associated with retinal neovascularization in patients with ischemic ocular diseases such as diabetic retinopathy, retinal vein occlusion, and retinopathy of prematurity. Intraocular expression of the angiogenic prote...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Aiello, L P, Pierce, E A, Foley, E D, Takagi, H, Chen, H, Riddle, L, Ferrara, N, King, G L, Smith, L E
Materyal Türü: Metin
Dil:İngilizce
Baskı/Yayın Bilgisi: 1995
Konular:
Research Article
Online Erişim:https://pmc.ncbi.nlm.nih.gov/articles/PMC40630/
https://pubmed.ncbi.nlm.nih.gov/7479819
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

https://pmc.ncbi.nlm.nih.gov/articles/PMC40630/
https://pubmed.ncbi.nlm.nih.gov/7479819

Benzer Materyaller